SARA HERRIN: Open Payments
NPI 1457709768 · SANDY SPRINGS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,104 in 92 payments from 40 companies in 2025. Trend: 2023 $1,559 · 2024 $1,915 · 2025 $2,104
Food & beverage: $2,104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $212 |
| AstraZeneca Pharmaceuticals LP | 7 | $186 |
| Novartis Pharmaceuticals Corporation | 9 | $162 |
| Daiichi Sankyo Inc. | 6 | $134 |
| Merck Sharp & Dohme LLC | 6 | $126 |
| Genentech USA, Inc. | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| GlaxoSmithKline, LLC. | 3 | $84 |
| Caris MPI, Inc. | 3 | $73 |
| PharmaEssentia USA Corporation | 2 | $57 |
Products named: KEYTRUDA, VENCLEXTA, Enhertu, EPKINLY, MI CANCER SEEK, KISQALI, EMRELIS, JEMPERLI.
Industry payments across GA — which companies pay providers there.
